Evaluation of the Efficacy and Safety of Nano-S1

计划入组 116 人 · 首次发布于 2023 年 4 月 20 日

Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL

首次发布于 2020 年 6 月 26 日

Limited Target Volume Radiotherapy After Glioblastoma Surgery

计划入组 79 人 · 首次发布于 2026 年 1 月 26 日

Liraglutide biosimilar(Biocon Limited)

Encochleated amphotericin B (Matinas BioPharma)

NeuGene (AVI BioPharma)

THERAVANCE BIOPHARMA IRELAND LIMITED

Ireland

DS BIOPHARMA LIMITED

Ireland

PRESTIGE BIOPHARMA LIMITED

Singapore

Splash Beverage Group Acquires Exclusive Global Rights to CannEpil for Drug-Resistant Epilepsy

New Antibiotic Approval Pathways Balance Urgent Medical Need with Limited Clinical Data

Dupilumab Shows Limited Success in Peanut Allergy Desensitization Study